Related Experiment Videos
Antibody response to Chlamydia pneumoniae infection in children with respiratory illness
A Kutlin1, P M Roblin, M R Hammerschlag
1Department of Pediatrics, State University of New York at Brooklyn, 11203-2098, USA.
Abstract:
Serologic diagnosis of Chlamydia pneumoniae infection has been based on the microimmunofluorescence test (MIF). However, recent prospective studies in children have found that >50% infected with C. pneumoniae failed to develop any antibodies detectable by MIF. In this study, single sera from 46 culture-positive and 42 culture-negative children with respiratory infection and known MIF status were examined by immunoblotting. Forty-one (89.1%) of the single sera from culture-positive and 27 (64.3%) from culture-negative children reacted to C. pneumoniae antigens in immunoblot. C. pneumoniae proteins most frequently recognized by sera from culture-positive patients were at 101-102, 72-76, 50-52, 48-49, 43-44, 41-42, and 30-31 kDa. However, there did not appear to be a correlation of specific band patterns and culture status.
Insights
The microimmunofluorescence test (MIF) often fails to detect Chlamydia pneumoniae antibodies in children. Immunoblotting shows higher reactivity in children with C. pneumoniae respiratory infections, offering a potentially more sensitive diagnostic method.
Area of Science:
- Medical Microbiology
- Immunology
- Pediatric Infectious Diseases
Background:
- Serologic diagnosis of Chlamydia pneumoniae infection traditionally relies on the microimmunofluorescence test (MIF).
- MIF has limitations, with over 50% of infected children failing to produce detectable antibodies.
- This necessitates exploring alternative diagnostic methods for C. pneumoniae in pediatric populations.
Purpose of the Study:
- To evaluate the utility of immunoblotting as a diagnostic tool for Chlamydia pneumoniae infection in children.
- To compare immunoblotting results with MIF and culture status in children with respiratory infections.
Main Methods:
- Single serum samples from 46 culture-positive and 42 culture-negative children with respiratory infections were analyzed.
- Immunoblotting was performed to detect antibodies against C. pneumoniae antigens.
- Results were compared with existing MIF status and culture results.
Main Results:
- Immunoblotting detected antibodies in 89.1% of culture-positive and 64.3% of culture-negative children.
- Key reactive C. pneumoniae antigens were identified at specific molecular weights (kDa) in culture-positive cases.
- No clear correlation was observed between specific immunoblotting band patterns and culture status.
Conclusions:
- Immunoblotting demonstrates higher sensitivity than MIF for detecting C. pneumoniae infection in children.
- This technique may improve serologic diagnosis of C. pneumoniae, especially in cases where MIF is inconclusive.
- Further research is warranted to refine immunoblotting protocols for pediatric C. pneumoniae diagnostics.